Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 7.3Cr 6.42Cr 5.99Cr 5.5Cr 10Cr 699.61Cr 11Cr 71Cr 28Cr 346.2Cr 27Cr 27Cr 1.2TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.39Cr 5.62Cr 5.24Cr 4.81Cr 9.01Cr 612.21Cr 9.23Cr 62Cr 24Cr 302.95Cr 24Cr 23Cr 1.05TCr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 7.3Cr | ||
| +0.43% | +6.46% | +0.52% | +14.25% | 4.89TCr | ||
| +1.90% | +24.70% | +27.25% | +9.47% | 4.07TCr | ||
| -1.60% | -1.15% | +388.84% | +603.70% | 3.85TCr | ||
| -0.98% | +2.28% | +7.02% | +45.34% | 3.64TCr | ||
| +1.47% | +5.82% | +5.76% | +43.52% | 2.84TCr | ||
| -0.94% | +0.05% | - | - | 1.66TCr | ||
| +2.44% | +10.76% | +30.59% | +129.56% | 1.63TCr | ||
| -1.14% | +6.52% | -3.80% | -29.33% | 1.36TCr | ||
| +0.23% | +3.99% | +4.15% | +9.97% | 1.36TCr | ||
| Average | -0.56% | +5.79% | +57.54% | +103.31% | 2.81TCr | |
| Weighted average by Cap. | +0.23% | +6.92% | +71.94% | +122.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.27L 13.32L 12.22L 22.88L 16Cr 23.44L 1.58Cr 61.76L 7.7Cr 60.97L 59.64L 27Cr | 1L 1L 1L 94.31T 2L 1.2Cr 2L 12.19L 5L 59.38L 5L 5L 2.05Cr |
| Net income | -1.27Cr -1.11Cr -1.04Cr -95.33L -1.78Cr -121.3Cr -1.83Cr -12Cr -4.82Cr -60Cr -4.75Cr -4.65Cr -207.51Cr | -23Cr -20Cr -19Cr -18Cr -33Cr -2.23TCr -34Cr -226.71Cr -89Cr -1.1TCr -88Cr -86Cr -3.82TCr |
| Net Debt | 13.96L 12.27L 11.45L 10.51L 19.67L 13Cr 20.16L 1.36Cr 53.11L 6.62Cr 52.42L 51.29L 23Cr | -91.25L -80.18L -74.84L -68.68L -1.29Cr -87Cr -1.32Cr -8.87Cr -3.47Cr -43Cr -3.43Cr -3.35Cr -149.51Cr |
Employees
-

















